Search results
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoThey have tips on what you need to know this season. (Getty Images) Vera Vita via Getty Images It’s...
Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan
Centers for Disease Control and Prevention· 9 hours agoPrevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 8 hours agoNovavax NVAX submitted an application to the FDA, seeking to amend its Emergency Use Authorization...
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 2 days agoIn June 2024 the FDA’s Vaccines and Related Biological Products Advisory Committee recommended the...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 5 days agoStates. KP.3 accounts for 25% of cases, while another variant, KP.2, makes up about 22% of cases....
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via Yahoo News· 24 hours agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
There’s A New COVID Variant, KP.3 – These Are The Symptoms
IFLScience· 4 days agoKP.3 is one of the FLiRT variants of SARS-CoV-2. The immune system can learn to recognize spike...
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
AZCentral | The Arizona Republic via Yahoo News· 7 days agoA new variant of COVID-19 called KP.3 is on the rise in the U.S. and has been detected in Arizona. The variant of ...
Hawaii-developed COVID home test kits being sold online
Honolulu Star-Advertiser· 9 hours agoA locally developed COVID-19 test kit is now on the market as cases of the contagious disease are on...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...